Two weeks before China disclosed it was investigating a cluster of mysterious pneumonia cases in Wuhan in late 2019 -- what the world now knows as Covid-19 -- South Korea’s top health officials gathered for a quarterly table-top exercise to plan their response to a theoretical health threat.
The hazard? A never-before-seen pathogen emerging in China that was causing a spike in pneumonia cases.
The timing was a fluke. But the war-gaming, and choice of subject, wasn’t. Korea had learned painful lessons from an outbreak just four years earlier of Middle East Respiratory Syndrome, or MERS. The country overhauled the